Skip to main content

Drugs

Ausgabe 3/2020

Inhalt (9 Artikel)

Leading Article

Novel Therapeutics for Recurrent Cervical Cancer: Moving Towards Personalized Therapy

Alexander C. Cohen, Brandon M. Roane, Charles A. Leath III

Review Article

In Search of the Long-Desired ‘Copernican Therapeutic Revolution’ in Small-Cell Lung Cancer

Noemí Reguart, Elba Marin, Jordi Remon, Roxana Reyes, Cristina Teixido

Review Article

Kratom (Mitragyna Speciosa) Liver Injury: A Comprehensive Review

Jonathan Schimmel, Richard C. Dart

Review Article

Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent

George G. Zhanel, Jenine Esquivel, Sheryl Zelenitsky, Courtney K. Lawrence, Heather J. Adam, Alyssa Golden, Rachel Hink, Liam Berry, Frank Schweizer, Michael A. Zhanel, Denice Bay, Philippe R. S. Lagacé-Wiens, Andrew J. Walkty, Joseph P. Lynch III, James A. Karlowsky

Adis Drug Evaluation

Ramucirumab: A Review in Hepatocellular Carcinoma

Yahiya Y. Syed

Open Access AdisInsight Report

Ubrogepant: First Approval

Lesley J. Scott

AdisInsight Report

Golodirsen: First Approval

Young-A Heo

AdisInsight Report

Givosiran: First Approval

Lesley J. Scott

Aktuelle Ausgaben